« Back to Research Deepdives

Can Omega-3’s Prevent Preterm Birth?

This content is restricted to members.

To view our premium content, sign up for a membership:

Register New Account

Username

First Name

Last Name

Password

Password Again

Choose your membership level

Monthly Membership - €24.99 - 1 Month
Full Education Hub access: the weekly Study Deepdive, bi-monthly video Research Lectures, Exclusive Articles, and the full backcatalog of Deepdives in downloadable pdf format.
Annual Membership - €249.99 - 1 Year
Access to all the Education Hub content, at a reduced annual rate.

Discount Code - Valid - Invalid

Choose Your Payment Method

Credit / Debit Card PayPal

I agree to the privacy policy

‹ Back to Research Deepdives

References

Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation 1-4. American Journal of Clinical Nutrition. 2009;89(2):678–84.
Shireman TI, Kerling EH, Gajewski BJ, Colombo J, Carlson SE. Docosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes. Prostaglandins Leukot Essent Fatty Acids. 2016 Aug;111:8–10.
Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, et al. DHA supplementation and pregnancy outcomes. American Journal of Clinical Nutrition. 2013;97(4):808–15.
Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N. The essentiality of arachidonic acid in infant development. Nutrients. 2016;8(4):216
Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, et al. Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. The Lancet. 2018;391:1830–41.
Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews. 2018 Nov 15;2018(11).
Yelland LN, Gajewski BJ, Colombo J, Gibson RA, Makrides M, Carlson SE. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2016 Sep;112:44–9.
Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juárez-Márquez S, et al. Effects of Docosahexaenoic Acid Supplementation During Pregnancy on Gestational Age and Size at Birth: Randomized, Double-Blind, Placebo-Controlled Trial in Mexico. Food Nutr Bull. 2010 Jun 15;31(2_suppl2):S108–16.
Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al. Effect of DHA Supplementation During Pregnancy on Maternal Depression and Neurodevelopment of Young Children. JAMA. 2010 Oct 20;304(15):1675.
Carlson SE, Gajewski BJ, Alhayek S, Colombo J, Kerling EH, Gustafson KM. Dose–response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight. Prostaglandins Leukot Essent Fatty Acids. 2018 Nov;138:1–5.
Makrides M, Best K, Yelland L, McPhee A, Zhou S, Quinlivan J, et al. A Randomized Trial of Prenatal n−3 Fatty Acid Supplementation and Preterm Delivery. New England Journal of Medicine. 2019 Sep 12;381(11):1035–45.
Carlson SE, Gajewski BJ, Valentine CJ, Rogers LK, Weiner CP, DeFranco EA, et al. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol. BMC Pregnancy Childbirth. 2017 Dec 13;17(1):62.
Simmonds L, Sullivan T, Skubisz M, Middleton P, Best K, Yelland L, et al. Omega‐3 fatty acid supplementation in pregnancy—baseline omega‐3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG. 2020 Jul 3;127(8):975–81.